--- title: Giraffe Bio aims its bespoke biomolecules at the looming... description: Giraffe Bio, a biotech startup, raised a $6.4 million seed round led by Orion Industrial Ventures (with BHP Ventures, Twynam, Air Capital, and Baruch Future... canonical: https://daily.dev/posts/giraffe-bio-aims-its-bespoke-biomolecules-at-the-looming-copper-shortage-phjskmgfp twitter:card: summary_large_image twitter:site: @dailydotdev og:type: website og:site_name: daily.dev og:title: Giraffe Bio aims its bespoke biomolecules at the looming copper shortage | daily.dev og:description: Giraffe Bio, a biotech startup, raised a $6.4 million seed round led by Orion Industrial Ventures (with BHP Ventures, Twynam, Air Capital, and Baruch Future... og:url: https://daily.dev/posts/giraffe-bio-aims-its-bespoke-biomolecules-at-the-looming-copper-shortage-phjskmgfp og:image: https://api.daily.dev/og/posts/pHJSkMgFP.png og:image:alt: Giraffe Bio aims its bespoke biomolecules at the looming copper shortage og:image:width: 1200 og:image:height: 630 og:locale: en --- > ## Documentation Index > Fetch the complete documentation index at: https://daily.dev/llms.txt > Use this file to discover all available pages before exploring further. # Giraffe Bio aims its bespoke biomolecules at the looming copper shortage **[TechCrunch](https://daily.dev/sources/tc)** · 3 min read · 0 upvotes · 0 comments ## Summary Giraffe Bio, a biotech startup, raised a $6.4 million seed round led by Orion Industrial Ventures (with BHP Ventures, Twynam, Air Capital, and Baruch Future Ventures participating) to commercialize mineral-specific biomolecules that help mines recover up to 5% more copper, well above the typical 1-2% gains from competing approaches. Unlike rivals such as Endolith, Ceibo, and Transition Metal Solutions, which pour live microbes into heap leaches, Giraffe Bio grows engineered microbes in a bioreactor to produce bespoke compounds used in flotation and as depressors, replacing some toxic chemicals in the process. The company plans to expand beyond copper to gold and silver. ## Full article daily.dev links to this article rather than hosting it. Read it at the original source: ## Questions this post answers ### How much more copper can Giraffe Bio's biomolecules help mines recover compared to typical methods? Giraffe Bio's mineral-specific chemicals can help mines recover up to 5% more copper, compared to the 1-2% improvement most competing methods achieve. The company engineers compounds tailored to each mine's specific mineral content, rather than using generic microbial treatments, which it says accounts for the higher yield. _Anyone tracking critical minerals innovation can follow biotech mining breakthroughs like this on daily.dev._ ### How does Giraffe Bio's approach to copper extraction differ from companies like Endolith and Ceibo that use live microbes? Giraffe Bio grows engineered microbes in a bioreactor to produce bespoke biomolecules, then inserts those compounds directly into a mine's existing flotation process, rather than dousing ores with live bacteria as Endolith and Ceibo do. This avoids the difficulty of keeping microbes alive in harsh mining environments while still leveraging the biological machinery that produces the beneficial compounds. _Developers and investors comparing biotech approaches to resource extraction can keep up with these startups on daily.dev._ ### How much funding did Giraffe Bio raise and who led the round? Giraffe Bio raised a $6.4 million seed round led by Orion Industrial Ventures, with participation from BHP Ventures, Twynam, Air Capital, and Baruch Future Ventures. The funding supports commercializing its bioreactor-grown, mineral-specific biomolecules for copper extraction, with plans to later target gold and silver. _Those watching climate and mining tech funding rounds can track emerging biotech startups via daily.dev._ ## Similar posts on daily.dev - [Microbes could extract the metal needed for cleantech](https://daily.dev/posts/microbes-could-extract-the-metal-needed-for-cleantech-ghrmuh1vt) · MIT Technology Review · 1 upvotes · 0 comments - [Munich’s mbiomics closes €30M to develop live bacterial product](https://daily.dev/posts/munich-s-mbiomics-closes-30m-to-develop-live-bacterial-product-wpdq9hcv1) · The Next Web · 0 upvotes · 0 comments - [Giving farmers a more sustainable way to protect crops](https://daily.dev/posts/giving-farmers-a-more-sustainable-way-to-protect-crops-zufzwjivz) · MIT News · 0 upvotes · 0 comments - [Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation](https://daily.dev/posts/colossal-biosciences-reportedly-in-talks-to-raise-new-capital-at-20b-30b-valuation-z61ebagxa) · TechCrunch · 3 upvotes · 0 comments - [How engineered microbes could help feed the world’s crops](https://daily.dev/posts/how-engineered-microbes-could-help-feed-the-world-s-crops-tj6hmgdxl) · MIT Technology Review · 0 upvotes · 0 comments --- Tags: [#startup](https://daily.dev/tags/startup), [#biotech](https://daily.dev/tags/biotech), [#climate-tech](https://daily.dev/tags/climate-tech) [View this post on daily.dev](https://daily.dev/posts/giraffe-bio-aims-its-bespoke-biomolecules-at-the-looming-copper-shortage-phjskmgfp) ```json {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://daily.dev/#organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180},"sameAs":["https://twitter.com/dailydotdev","https://github.com/dailydotdev","https://www.linkedin.com/company/daily-dev-ltd"]},{"@type":"WebSite","@id":"https://daily.dev/#website","url":"https://daily.dev","name":"daily.dev","publisher":{"@id":"https://daily.dev/#organization"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://daily.dev/search?q={search_term_string}"},"query-input":"required name=search_term_string"}}]} {"@context":"https://schema.org","@type":"TechArticle","headline":"Giraffe Bio aims its bespoke biomolecules at the looming copper shortage","url":"https://daily.dev/posts/giraffe-bio-aims-its-bespoke-biomolecules-at-the-looming-copper-shortage-phjskmgfp","mainEntityOfPage":{"@type":"WebPage","@id":"https://daily.dev/posts/giraffe-bio-aims-its-bespoke-biomolecules-at-the-looming-copper-shortage-phjskmgfp"},"datePublished":"2026-10-13T12:44:34.409Z","dateModified":"2026-10-13T18:03:40.967Z","description":"Giraffe Bio, a biotech startup, raised a $6.4 million seed round led by Orion Industrial Ventures (with BHP Ventures, Twynam, Air Capital, and Baruch Future...","image":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/43cc21de5cd8df6eea7911befcf1e487?_a=AQAEuop","thumbnailUrl":"https://media.daily.dev/image/upload/f_auto,q_auto/v1/posts/43cc21de5cd8df6eea7911befcf1e487?_a=AQAEuop","isAccessibleForFree":true,"articleSection":"TechCrunch","inLanguage":"en","publisher":{"@type":"Organization","name":"daily.dev","url":"https://daily.dev","logo":{"@type":"ImageObject","url":"https://daily.dev/apple-touch-icon.png","width":180,"height":180}},"author":{"@type":"Organization","name":"TechCrunch","logo":"https://media.daily.dev/image/upload/t_logo,f_auto/v1/logos/tc","url":"https://daily.dev/sources/tc"},"commentCount":0,"discussionUrl":"https://daily.dev/posts/giraffe-bio-aims-its-bespoke-biomolecules-at-the-looming-copper-shortage-phjskmgfp","interactionStatistic":[{"@type":"InteractionCounter","interactionType":{"@type":"LikeAction"},"userInteractionCount":0},{"@type":"InteractionCounter","interactionType":{"@type":"CommentAction"},"userInteractionCount":0}],"keywords":"startup,biotech,climate-tech","timeRequired":"PT3M"} {"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://daily.dev"},{"@type":"ListItem","position":2,"name":"TechCrunch","item":"https://daily.dev/sources/tc"},{"@type":"ListItem","position":3,"name":"Giraffe Bio aims its bespoke biomolecules at the looming copper shortage"}]} {"@context":"https://schema.org","@type":"FAQPage","@id":"https://daily.dev/posts/giraffe-bio-aims-its-bespoke-biomolecules-at-the-looming-copper-shortage-phjskmgfp#faq","mainEntity":[{"@type":"Question","name":"How much more copper can Giraffe Bio's biomolecules help mines recover compared to typical methods?","acceptedAnswer":{"@type":"Answer","text":"Giraffe Bio's mineral-specific chemicals can help mines recover up to 5% more copper, compared to the 1-2% improvement most competing methods achieve. The company engineers compounds tailored to each mine's specific mineral content, rather than using generic microbial treatments, which it says accounts for the higher yield. Anyone tracking critical minerals innovation can follow biotech mining breakthroughs like this on daily.dev."}},{"@type":"Question","name":"How does Giraffe Bio's approach to copper extraction differ from companies like Endolith and Ceibo that use live microbes?","acceptedAnswer":{"@type":"Answer","text":"Giraffe Bio grows engineered microbes in a bioreactor to produce bespoke biomolecules, then inserts those compounds directly into a mine's existing flotation process, rather than dousing ores with live bacteria as Endolith and Ceibo do. This avoids the difficulty of keeping microbes alive in harsh mining environments while still leveraging the biological machinery that produces the beneficial compounds. Developers and investors comparing biotech approaches to resource extraction can keep up with these startups on daily.dev."}},{"@type":"Question","name":"How much funding did Giraffe Bio raise and who led the round?","acceptedAnswer":{"@type":"Answer","text":"Giraffe Bio raised a $6.4 million seed round led by Orion Industrial Ventures, with participation from BHP Ventures, Twynam, Air Capital, and Baruch Future Ventures. The funding supports commercializing its bioreactor-grown, mineral-specific biomolecules for copper extraction, with plans to later target gold and silver. Those watching climate and mining tech funding rounds can track emerging biotech startups via daily.dev."}}]} ```